Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Crizotinib, an orally bioavailable agent, belongs to the class of c-met/hepatocyte growth factor receptor (HGFR) tyrosine kinase inhibitors with potential antineoplastic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,670.00 | |
50 mg | 6-8 weeks | $ 2,180.00 | |
100 mg | 6-8 weeks | $ 2,800.00 |
Description | Crizotinib, an orally bioavailable agent, belongs to the class of c-met/hepatocyte growth factor receptor (HGFR) tyrosine kinase inhibitors with potential antineoplastic activity. |
Synonyms | PF02341066, PF-2341066, PF 02341066, PF-02341066, PF2341066 |
Molecular Weight | 510.39 |
Formula | C23H26Cl2FN5O3 |
CAS No. | 877399-53-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Crizotinib acetate 877399-53-6 PF02341066 PF-2341066 PF 02341066 PF-02341066 Crizotinib Acetate PF2341066 PF 2341066 inhibitor inhibit